Stocks and InvestingStocks and Investing
Wed, January 17, 2024
Tue, January 16, 2024
Mon, January 15, 2024
Fri, January 12, 2024

Olivia Brayer Reiterated (VRTX) at Buy and Held Target at $415 on, Jan 12th, 2024


Published on 2024-10-28 08:20:27 - WOPRAI, Olivia Brayer
  Print publication without navigation


Olivia Brayer of Cantor Fitzgerald, Reiterated "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy and Held Target at $415 on, Jan 12th, 2024.

Olivia has made no other calls on VRTX in the last 4 months.



There are 8 other peers that have a rating on VRTX. Out of the 8 peers that are also analyzing VRTX, 3 agree with Olivia's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Maintained at Hold with Increased Target to $379 on, Thursday, December 14th, 2023
  • Paul Matteis of "Stifel" Reiterated at Hold and Held Target at $373 on, Wednesday, November 22nd, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $364 on, Wednesday, November 8th, 2023


These are the ratings of the 5 analyists that currently disagree with Olivia


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $397 on, Monday, December 11th, 2023
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $415 on, Monday, December 11th, 2023
  • Evan Seigerman of "BMO Capital" Maintained at Buy with Increased Target to $415 on, Tuesday, November 7th, 2023
  • Eric Schmidt of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $370 on, Tuesday, October 17th, 2023
  • Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $456 on, Wednesday, October 4th, 2023